UNSPSC 51452504: Cyfluthrin

This classification denotes a pesticide with the molecular formula C22H18Cl2FNO3, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier SCM2QLZ6S0, chemically known as 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylic acid, cyano(4-fluoro-3-phenoxyphenyl)methyl ester but more generally known as cyfluthrin, which bears U.S. National Institutes of Health Compound Identifier 50153. World Health Organization schedules cyfluthrin in its Anatomical Therapeutic Chemical (ATC) Classification and its WHO-DD or Drug Dictionary.

UNSPSC 51452504 Cyfluthrin, a Commodity code, shows no recent state and local procurement activity aligned with its nominal scope—the code represents a specific synthetic pyrethroid insecticide used in pest control and agricultural applications. The four most recent opportunities tagged under this code involve naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, medical and first aid supplies for emergency response, and generic pharmaceuticals and over-the-counter products through cooperative purchasing. None of these solicitations concern cyfluthrin or insecticidal products, indicating a significant mismatch between the code's intended commodity classification and the actual work state and local governments are buying under this tag.

The geographic spread of recent opportunities spans Florida, Texas, and Minnesota through different issuing bodies—Seminole County (health and community initiatives), the Texas Health and Human Services Commission (state-level pharmacy benefit strategy), the City of Tampa Fire Department (emergency medical supplies), and the Minnesota Multistate Cooperative Purchasing Alliance (multi-state pharmaceutical contracting). The representative solicitations include Seminole County's IFB for naloxone and drug deactivation systems with a response date of July 26, 2023; the City of Tampa's IFB for medical and first aid supplies (estimated $700,000) with a March 13, 2026 deadline and a certified Small Local Business Enterprise set-aside; and MMCAP's RFP for generic pharmaceuticals and OTC products closing March 26, 2026, serving multiple state and local jurisdictions. The code does not reflect active market demand for cyfluthrin itself among state and local buyers.